Amosulalol hydrochloride

This classification denotes an adrenergic antagonist with the molecular formula C18H24N2O5S.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4O4S698PEE, chemically known as benzenesulfonamide, 5-(1-hydroxy-2-((2-(2-methoxyphenoxy)ethyl)amino)ethyl)-2-methyl-, monohydrochloride but more generally known as amosulalol hydrochloride, which bears US NIH Compound Identifier 123707. The base compound, Amosulalol, most often comes in base and hydrochloride forms. European Medicines Agency schedules Amosulalol hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00502MIG. Most nations, for tariff and trade purposes, schedule amosulalol hydrochloride under HS 29350090 and SITC 51580. As of Q4 2014, AMOSULALOL HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. SMILES: CC1CCC(CC1S(=O)(=O)N)C(CNCCOC2CCCCC2OC)O.CL.